CaRi-Plaque (K242240)
Description
CaRi-Plaque by Caristo Diagnostics , Ltd., an FDA 510(k) cleared radiology device.
Regulatory Information
FDA Database
View on FDA DatabaseCategories
Predicate lineage for K242240
A 510(k) clearance is granted by showing substantial equivalence to an earlier legally marketed device, called the predicate. This lineage is named in the 510(k) summary document and is not published by the FDA as a connected dataset. CaRi-Plaque (K242240) cites 2 predicate devices and is itself cited by 1 later device.
Predicate devices cited by this clearance
| K number | Device | Applicant | Year |
|---|---|---|---|
| K212758 | Autoplaque | Cedars-Sinai Medical Center: Aim | 2023 |
| K200274 | CariCloud | Caristo Diagnostics | 2020 |
Later devices that cite this one as their predicate
| K number | Device | Applicant | Year |
|---|---|---|---|
| K251837 | Salix Coronary Plaque (V1.0.0) | Artrya Limited | 2025 |
Trace the full predicate network for K242240
A link appears here only where the predicate could be read from a published 510(k) summary. Where no summary exists or a reference cannot be resolved to a K number, no link is drawn, so a gap means unknown rather than none.